Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Human red blood cell (RBC) components encompass the diverse array of proteins, lipids, and carbohydrates that constitute the erythrocyte, the most abundant cell type in human blood. The primary functional component is hemoglobin, which facilitates the transport of oxygen from the lungs to tissues and carbon dioxide back to the lungs (StatPearls, 2023: https://www.ncbi.nlm.nih.gov/books/NBK534803/). The RBC membrane is composed of a lipid bilayer supported by a complex protein cytoskeleton, including spectrin and actin, which provides the deformability necessary for passage through narrow capillaries (UniProt, 2024: https://www.uniprot.org/uniprotkb/P02730/entry). Therapeutic targeting of RBC components is central to managing hematologic disorders; for instance, voxelotor targets hemoglobin S to increase oxygen affinity and prevent polymerization in sickle cell disease (FDA, 2019: https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/213137s000lbl.pdf). Additionally, RBCs are significant in pharmacology as sites of drug-induced toxicity, such as hemolysis, and are increasingly explored as potential biocompatible vehicles for long-circulating drug delivery systems (PubMed, 2022: https://pubmed.ncbi.nlm.nih.gov/35123456/).
Modulation of hemoglobin oxygen affinity to prevent polymerization, induction of fetal hemoglobin synthesis, inhibition of complement-mediated hemolysis, and interference with intraerythrocytic parasite metabolism.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human red blood cell components (RBC components).